Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug 30;106(1):370.
doi: 10.4269/ajtmh.21-0836b.

Response to "Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy"

Sherief Abd-Elsalam, Shaimaa Soliman
Comment

Response to "Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy"

Sherief Abd-Elsalam et al. Am J Trop Med Hyg. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Mol BW. Randomized controlled trials on COVID-19 should be accurate and trustworthy. Am J Trop Med Hyg 105: 1127. - PMC - PubMed
    1. Abd-Elsalam S, Esmail ES, Khalaf M, Abdo EF, Medhat MA, Abd El Ghafar MS, Ahmed OA, Soliman S, Serangawy GN, Alboraie M, 2020. Hydroxychloroquine in the treatment of COVID-19: a multicenter randomized controlled study. Am J Trop Med Hyg 103: 1635–1639. - PMC - PubMed
    1. Axfors C. et al., 2021. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun 12: 2349. - PMC - PubMed
    1. Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA, 2021. Efficacy of favipiravir in COVID‐19 treatment: a multi‐center randomized study. Arch Virol 166: 949–954. - PMC - PubMed
    1. Dabbous HM. et al., 2021. Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID‐19: a randomised controlled trial. Sci Rep 11: 7282. - PMC - PubMed